Product details
Survodutide (development code BI 456906) is an investigational dual GLP-1 / glucagon receptor co-agonist. Like Mazdutide it engages the GLP-1 and glucagon arms and omits GIP, which places both molecules in the same receptor-coverage bracket — distinct from the GIP-containing dual and tri-agonist peptides — and makes Survodutide a reference tool for glucagon-pathway pharmacology studied alongside the GLP-1 axis. As an investigational compound it is not an approved finished drug; the material supplied here is a research reagent only.
Peptuno characterizes each Survodutide lot as an analytical reference standard. Because the structure is close enough to other GLP-1 / glucagon dual agonists that catalog-level confusion is possible, the packet leads with ESI-MS identity confirmation alongside RP-HPLC purity (gradient method, UV 214 nm), counter-ion content, and water content by Karl Fischer; LC-MS/MS sequence verification is recommended on first-time orders. The commonly cited CAS should be confirmed against the lot COA. Fills run mg-scale for reproducible aliquoting; this is reference-grade research material, distinct from compounding-scale API supply.
Regulatory note: Investigational compound in clinical development; not approved as a finished drug at the time of writing. Sold for Research Use Only under the receiving laboratory's institutional and jurisdictional regulations — not a finished dosage form and not labelled for human administration. CAS is commonly cited but should be verified per batch COA. Buyers are responsible for institutional biosafety review and verifying import eligibility in the destination market.
FAQ
- What distinguishes Survodutide from Mazdutide as reference standards?
- Both are dual GLP-1 / glucagon co-agonists with no GIP arm, so at the receptor-coverage level they share a bracket; they differ in peptide sequence and lipidation chemistry, and they trace to different clinical-development programs. For reference-standard selection the practical driver is matching the molecule to the data set a study cites. Confirm exact identity per batch COA before treating the two as interchangeable.
- Why does Peptuno lead the Survodutide packet with mass-spec identity?
- Several GLP-1 / glucagon dual agonists are structurally similar enough that a catalog listing alone is not a reliable identity statement. Leading with ESI-MS against the theoretical mass for the supplied form — reproduced on the COA — gives a lab a citable, batch-level identity check, with LC-MS/MS sequence verification available on request for first-time qualification.
- What documentation ships with a Survodutide lot?
- Each lot ships with RP-HPLC purity (gradient method, 214 nm), ESI-MS identity against the theoretical mass for the supplied form, counter-ion content, and water content by Karl Fischer, with the chromatogram and mass-spec values reproduced on the COA for direct citation. LC-MS/MS sequence verification and bacterial endotoxin (LAL) are on-request add-ons for first-time qualification and in vivo work respectively.
Certificate of Analysis (COA)
The per-lot COA for this product will appear here.